Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Addictions
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Addictions
    TopAbstracts in Addictions 12/25/2008 - (DGNews)
    TopAbstracts in Addictions 12/11/2008 - (DGNews)
    Patterns of abuse among unintentional pharmaceutical overdose fatalities - (JAMA)
    Unintentional Overdose Deaths Associated With Nonmedical Use of Prescription Pain Relievers - (DGNews)
    TopAbstracts in Addictions 11/27/2008 - (DGNews)

    News archive

     Recent webcasts/CME - Addictions
      Fetal Alcohol Spectrum Disorders (FASD): What it as and How it Affects the Child, the Family and Society: FASD and its Effects II
      Fetal Alcohol Spectrum Disorders (FASD): What it is and How it Affects the Child, the Family and Society: FASD and its Effects I
      More Than Brief Intervention: Updating Smoking Cessation Treatment for Pulmonary Patients
      Balanced Opioid Prescribing
      Opioid Addiction: No Reason to Withhold Pain Management

      Webcasts/CME archive

       Recent cases - Addictions
        Rare Case of Cefotaxime Induced Leukocytoclastic Vasculitis in Alcoholic Cirrhosis Patient
        Cystitis Due to the Use of Ketamine as a Recreational Drug: A Case Report
        Decrease in Tobacco Consumption After Treatment with Topiramate and Aripiprazole
        Calcific Myofibrosis Due to Pentazocine Abuse: A Case Report
        A Novel SPINK1 Gene Mutation, c.206C>T, in a Thai Patient with Chronic Alcoholic Pancreatitis

        Cases archive
          




        my personal edition > addictions > news
        divider

          E-Mail this DGReview to a colleague

        DGReview


        Memory Impairment from Ecstasy Use May Not Be Reversible

        Archives of General Psychiatry

        10/16/2001
        By Elda Hauschildt


        Even a year after they have stopped using, people who take 3,4 methylenedioxymethamphetamine (MDMA or ecstasy) still have impaired memory function.

        This indicates that the functional consequences on cortical brain serotonin (5-HT) neurons of MDMA use may not be reversible, Dutch researchers say.

        They suggest that neurotoxic changes seen in cortical 5-HT brain neurons from MDMA use may be reversible, however.

        "In individuals who stopped using MDMA more than one year earlier, cortical 5-HT transporter (SERT) densities did not differ from those of control subjects, whereas recent MDMA users showed global decreases in SERTs," investigators explain.

        "Our findings also indicate that individuals who stopped using MDMA had a deficit in verbal memory, similar to that of current MDMA users, and that higher lifetime doses of MDMA are associated with greater decrements in immediate verbal memory function."

        Investigators add that the observed decreases in cortical SERT densities in recent-users most likely reflect MDMA-induced brain 5-HT neurotoxic effects.

        "Absence of decreases in SERT densities in ex-MDMA users suggests reversibility of MDMA-induced changes in brain SERTS in MDMA users," they point out.

        Researchers from the Graduate School of Neurosciences, the Amsterdam Institute for Addiction Research and Leiden University Medical Centre in the Netherlands say the implications of their findings are relevant to anyone deciding to take MDMA.

        "We identified that MDMA use is associated not only with short-term consequences but also with long-term consequences as well.

        "These findings will provide a cogent argument for consumers to make informed decisions about recreational drug use."

        They also suggest studying MDMA-exposed people with highly selective brain SERT deficits "adds to our knowledge about a neurotransmission system thought to be involved in the cause and treatment of very common psychiatric illnesses, such as depression."

        Investigators studied 22 recent MDMA users, 16 ex-MDMA users and 13 controls. They defined ex-users as people who had stopped using the drug more than one year earlier.

        They used single-photon emission computer tomography to examine the effects of MDMA use on cortical 5-HT neurons. They measured verbal memory performance with the Rey Auditory Verbal Learning Test.

        "Recent and ex-MDMA users recalled significantly fewer words than did controls on the immediate recall as well as the delayed recall," the researchers report.

        "Greater use of MDMA was associated with greater impairment in immediate verbal memory."

        Researchers say the consequences of lost serotonergic reserve later in life are difficult to predict but could be clinically significant. That makes prospective studies of psychiatric morbidity in MDMA users necessary so that future demands on health care can be estimated.
        Archives of General Psychiatry, 2001; 58: 901-906.

        E-Mail this DGReview to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send